Evaluating Long-Term Benefits of Chronic Azithromycin. Furthering Our Quest for Precision Medicine

This publication has 23 references indexed in Scilit:

• Treatment Setting and Outcomes of Cystic Fibrosis Pulmonary Exacerbations
  Annals of the American Thoracic Society, 2018
• Azithromycin and Chloramphenicol Diminish Neutrophil Extracellular Traps (NETs) Release
  International Journal of Molecular Sciences, 2017
• Impact of azithromycin on the clinical and antimicrobial effectiveness of tobramycin in the treatment of cystic fibrosis
  Journal of Cystic Fibrosis, 2017
• The Cystic Fibrosis Foundation Patient Registry. Design and Methods of a National Observational Disease Registry
  Annals of the American Thoracic Society, 2016
• Pulmonary Medication Adherence and Health-care Use in Cystic Fibrosis
  Chest, 2014
• Azithromycin May Antagonize Inhaled Tobramycin When Targeting Pseudomonas aeruginosa in Cystic Fibrosis
  Annals of the American Thoracic Society, 2014
• Inhaled Tobramycin Effectively Reduces FEV1 Decline in Cystic Fibrosis. An Instrumental Variables Analysis
  Annals of the American Thoracic Society, 2013
• Macrolide antibiotics for cystic fibrosis
  Cochrane Database of Systematic Reviews, 2012
• Effect of Azithromycin on Systemic Markers of Inflammation in Patients With Cystic Fibrosis Uninfected With Pseudomonas aeruginosa
  Chest, 2012
• Diffuse panbronchiolitis and cystic fibrosis: East meets West.
  Thorax, 1994